0 CHECKOUT

PRODUCT FILTERS

REGION

14,330
10,821
10,749
10,043
9,999

COUNTRY

9,611
1,185
510
489
432

CATEGORIES

  • 3,017
  • 2,776
    • 333
    • 318
    • 252
    • 247
    • 211
    • 190
    • 186
    • 150
    • 149
    • 138
    • 134
    • 134
    • 102
    • 100
  • 2,644
    • 224
  • 2,299
  • 2,094
    • 158
  • 2,051
    • 200
    • 160
  • 1,479
  • 1,432
    • 310
    • 285
  • 1,375
  • 1,360
  • 1,342
  • 1,069
  • 1,029
  • 1,007
  • 1,006
    • 253
  • 741
    • 287
    • 210
  • 629
  • 572
    • 206
    • 160
  • 431
  • 420
  • 391
  • 173
  • 132
  • 116
  • 109
SHOW ALL

PRICE

5,407
10,296
17,777
33,853

PUBLISHED

2,230
6,228
16,286
33,853

PRODUCT TYPE

26,669
2,794
2,702
732
567
225
77
32
31
17
6
1

Pharmaceuticals Market Research Reports

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. Show Less Read more

Dental Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Dental Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  March 2016
Price:  From

Thrombocythaemia Myelofibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Thrombocythaemia Myelofibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase...

Published:  March 2016
Price:  From

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Herpes Zoster (Shingles)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Herpes Zoster (Shingles)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Eczema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Eczema-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and...

Published:  March 2016
Price:  From

Dysuria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Dysuria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  March 2016
Price:  From

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Bipolar Disorder (Manic Depression)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales,...

Published:  March 2016
Price:  From

Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Anxiety Disorders-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Alcohol Addiction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Alcohol Addiction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Acute Bacterial Sinusitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Acute Bacterial Sinusitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Myasthenia Gravis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Myasthenia Gravis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Mixed Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Mixed Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs,...

Published:  March 2016
Price:  From

Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Metastatic Melanoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  March 2016
Price:  From

Dyskinesia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Dyskinesia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs...

Published:  March 2016
Price:  From

Diabetic Neuropathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Diabetic Neuropathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients